Switching to venetoclax led to sustained high rates of undetectable minimal residual disease, the investigators found.

To combat the onslaught of litigation, Bayer has been pushing legislation in nine states, that would shield the company from ...

Worsening a patient's credit can prevent them from getting a job, renting an apartment, or even paying their outstanding ...

A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute myeloid leukemia, one of the most aggressive and fatal blood cancers in adults.

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...